Available to SourceHuman Prescription Drug
Amjevita (Adalimumab-Atto)
40 mg/.4mL · Injection
By Nuvaila Limited
Adalimumab-Atto · Injection · 40 mg/.4mL · Subcutaneous
- NDC
- 84612-482
- Route
- Subcutaneous
- Therapeutic class
- Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker , Tumor Necrosis Factor Receptor Blocking Activity [MoA]
- Marketing category
- BLA
Package sizes
- 1 SYRINGE in 1 CARTON (84612-482-01) / .4 mL in 1 SYRINGENDC 84612-482-01Available to Order
- 2 SYRINGE in 1 CARTON (84612-482-02) / .4 mL in 1 SYRINGENDC 84612-482-02Available to Order
Request This Medication
*Expect a reply within 2 business hours with availability and pricing.
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request a quote
Request this medication.
Pick the package size you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.
- DSCSA-compliant pedigree on every order
- Cold-chain capable where applicable
- Same-day fulfillment available for urgent needs